Novel links between HIFs, type 2 diabetes, and metabolic syndrome.
about
Reactive oxygen species, nutrition, hypoxia and diseases: Problems solved?HIF-prolyl hydroxylases as therapeutic targets in erythropoiesis and iron metabolismInterplay between 3'-UTR polymorphisms in the vascular endothelial growth factor (VEGF) gene and metabolic syndrome in determining the risk of colorectal cancer in Koreans.Alveolar-capillary adaptation to chronic hypoxia in the fatty lung.Hypoxia-inducible factor 1α regulates a SOCS3-STAT3-adiponectin signal transduction pathway in adipocytes.Increased Expression of EGR-1 in Diabetic Human Adipose Tissue-Derived Mesenchymal Stem Cells Reduces Their Wound Healing Capacity.DNA methylation and gene expression of HIF3A: cross-tissue validation and associations with BMI and insulin resistance.Synthesis and Biological Evaluation of Iodoglucoazomycin (I-GAZ), an Azomycin-Glucose Adduct with Putative Applications in Diagnostic Imaging and Radiotherapy of Hypoxic TumorsActivation of hypoxia-inducible factor-2 in adipocytes results in pathological cardiac hypertrophyThe role of vitamin D in skeletal and cardiac muscle functionImpaired hypoxia-inducible factor (HIF) regulation by hyperglycemia.The Hypoxia-Inducible Factor Pathway in Adipocytes: The Role of HIF-2 in Adipose Inflammation and Hypertrophic Cardiomyopathy.A2A adenosine receptors control pancreatic dysfunction in high-fat-diet induced obesity.Intermittent hypoxia training in prediabetes patients: Beneficial effects on glucose homeostasis, hypoxia tolerance and gene expression.Regulation of obesity and insulin resistance by hypoxia-inducible factors.Metabolism-Centric Overview of the Pathogenesis of Alzheimer's Disease.Sweet and sour β-cells: ROS and Hif1α induce Warburg-like lactate production during type 2 diabetes.Fumarate Hydratase Deletion in Pancreatic β Cells Leads to Progressive DiabetesEpigenetic reprogramming in metabolic disorders: nutritional factors and beyond.Impact of intermittent hypoxia and exercise on blood pressure and metabolic features from obese subjects suffering sleep apnea-hypopnea syndrome.Mitigating hypoxic stress on pancreatic islets via in situ oxygen generating biomaterial.The Factor Inhibiting HIF Asparaginyl Hydroxylase Regulates Oxidative Metabolism and Accelerates Metabolic Adaptation to Hypoxia.Hypoxia Inducible Factor as a Central Regulator of Metabolism - Implications for the Development of Obesity
P2860
Q26784413-32F50225-625B-431C-8CBF-4F70C4E61072Q33926530-CFB42FD8-800B-48C7-A8A1-BBB8226F61CBQ34894525-51ACE3ED-DF07-4759-8BE4-47CCECBC5A37Q35181351-0B9AF4F3-5820-4316-A02D-2324EFE9BF91Q36596160-05A4688D-A4CF-4A9D-A8A9-0E725B08E8AFQ36910723-0A9CB69E-EA24-4EC1-8AEB-DD8DCBB58166Q37230787-4032EDB5-B21B-4E2B-BBA0-38B894A0EED9Q37394242-D7AE730D-D0D1-48A2-90B2-412DB46BB4DBQ37457670-BCD4A08E-89A5-45E7-B646-600AE15E7F2BQ37715719-F6A2B9EE-D454-493E-8CC4-4D726113854FQ38229803-C440D1E3-1BD2-4B0A-8587-44E63A8D1DE0Q38410928-1E489E6C-C5F9-45A5-B9AB-31E983B1FEADQ38648091-BE05A750-CF59-4298-9E93-268C10837AB4Q38652332-99C413B6-54CB-41B4-9C8C-E3BC662E3337Q38989143-3678B6DC-0418-47D8-BE48-FCD2F06FBA76Q39195275-06F952E0-9957-489A-A2C7-35774474AAFDQ40945887-DA335EB0-0F7B-4911-9F48-15B093A31C9EQ42375129-63FF1291-C7C1-44C9-82C4-462C9ABBB5A0Q45073386-4064A515-C86E-48F0-8F10-7D4233FAC9B4Q47977512-44759E0D-D140-4CFF-A399-058D66D07C0AQ50945853-F9C524B9-17B9-4B64-9B37-B7C310DBC96BQ55085694-B11A1400-97A9-49EC-97F0-2F8785827A4FQ59137763-1E86ED5B-7D4B-4C59-856A-DCE8B63E36F3
P2860
Novel links between HIFs, type 2 diabetes, and metabolic syndrome.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Novel links between HIFs, type 2 diabetes, and metabolic syndrome.
@en
type
label
Novel links between HIFs, type 2 diabetes, and metabolic syndrome.
@en
prefLabel
Novel links between HIFs, type 2 diabetes, and metabolic syndrome.
@en
P2093
P1476
Novel links between HIFs, type 2 diabetes, and metabolic syndrome.
@en
P2093
Christian M Girgis
Christopher H Scott
Jenny E Gunton
P304
P356
10.1016/J.TEM.2012.05.003
P577
2012-07-04T00:00:00Z